Screener
Context Therapeutics Inc. CNTX Q1 2026 earnings
Reported May 6, 2026 · Before market open
EPS-$0.09Beat by $0.03
EPS estimate-$0.12
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
Diluted EPS
FAQ
- When did Context Therapeutics Inc. report Q1 2026 earnings?
- Context Therapeutics Inc. (CNTX) reported Q1 2026 earnings on May 6, 2026 before market open.
- What were Context Therapeutics Inc.'s Q1 2026 revenue and EPS?
- Context Therapeutics Inc. reported eps of $-0.09 for Q1 2026.
- Did Context Therapeutics Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.12 by $0.03.
- How did Context Therapeutics Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 80.0% from $-0.05.
- Where can I find Context Therapeutics Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001628280-26-031267) directly on SEC EDGAR. The filing index links above go to sec.gov.
